FDA Panel Backs GRAIL's Galleri Multi-Cancer Detection Test
The US Food and Drug Administration advisory panel backed Galleri’s safety and voted that its benefits outweigh risks, while six of 10 members supported its effectiveness.
Multiple Cancer | 25/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy